Charles River Laboratories (CRL)

232.64
+0.87(+0.38%)
After Hours
232.64
0.00(0.00%)
- Real-time Data
  • Volume:
    368,486
  • Day's Range:
    226.08 - 236.06
  • 52 wk Range:
    217.20 - 460.21

CRL Overview

Prev. Close
231.77
Day's Range
226.08-236.06
Revenue
3.63B
Open
234.15
52 wk Range
217.2-460.21
EPS
8.21
Volume
368,486
Market Cap
11.82B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
568,607
P/E Ratio
28.35
Beta
1.25
1-Year Change
-28.91%
Shares Outstanding
50,804,860
Next Earnings Date
Aug 10, 2022
What is your sentiment on Charles River Laboratories?
or
Market is currently closed. Voting is open during market hours.

Charles River Laboratories News

Charles River Laboratories Analysis

Charles River Laboratories Company Profile

Charles River Laboratories Company Profile

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellSell
Technical IndicatorsStrong BuyStrong BuyBuySellStrong Sell
SummaryStrong BuyStrong BuyBuySellStrong Sell
  • The Fed's minutes from the January meeting, set to be released on Wednesday, will return focus to monetary policy, and the prospect of aggressive rate hikes ahead. 
    0
    • Huge bubble, S&P PE @39!! scarly , its just next to the 2008! BE COUTIONS!
      3
      • My army says hello...
        0
        • 77-190 USB foct
          0